Payam Tabarsi to Male
This is a "connection" page, showing publications Payam Tabarsi has written about Male.
Connection Strength
0.149
-
Combination therapy of IFNß1 with lopinavir-ritonavir, increases oxygenation, survival and discharging of sever COVID-19 infected inpatients. Int Immunopharmacol. 2021 Mar; 92:107329.
Score: 0.012
-
Evaluating the effects of Intravenous Immunoglobulin (IVIg) on the management of severe COVID-19 cases: A randomized controlled trial. Int Immunopharmacol. 2021 Jan; 90:107205.
Score: 0.012
-
Subcutaneous tocilizumab in adults with severe and critical COVID-19: A prospective open-label uncontrolled multicenter trial. Int Immunopharmacol. 2020 Dec; 89(Pt B):107102.
Score: 0.012
-
Promising effects of tocilizumab in COVID-19: A non-controlled, prospective clinical trial. Int Immunopharmacol. 2020 Nov; 88:106869.
Score: 0.012
-
Subcutaneous administration of interferon beta-1a for COVID-19: A non-controlled prospective trial. Int Immunopharmacol. 2020 Aug; 85:106688.
Score: 0.012
-
Tocilizumab administration in a refractory case of COVID-19. Int J Antimicrob Agents. 2020 Aug; 56(2):106043.
Score: 0.012
-
An adult autosomal recessive chronic granulomatous disease patient with pulmonary Aspergillus terreus infection. BMC Infect Dis. 2018 Nov 08; 18(1):552.
Score: 0.011
-
Diagnosis of COVID-19 by Serology in Admitted Patients with Negative RT-PCR Assay. Iran J Allergy Asthma Immunol. 2021 Aug 07; 20(4):394-401.
Score: 0.003
-
Combined Therapy of Ciclosporin Plus Favipiravir in the Management of Patients with Severe COVID-19, not Responding to Dexamethasone: A non-Controlled Prospective Trial. Int Immunopharmacol. 2021 Oct; 99:108043.
Score: 0.003
-
Increased Serum Levels of Soluble TNF-a Receptor Is Associated With ICU Mortality in COVID-19 Patients. Front Immunol. 2021; 12:592727.
Score: 0.003
-
Prevalence of Anti-SARS-CoV-2 Specific Antibodies in Health-Care Workers Compared to General Population during an Early Phase of the Pandemic, Tehran-Iran. Iran J Immunol. 2021 03; 18(1):82-92.
Score: 0.003
-
No clinical benefit of high dose corticosteroid administration in patients with COVID-19: A preliminary report of a randomized clinical trial. Eur J Pharmacol. 2021 Apr 15; 897:173947.
Score: 0.003
-
Serum cytokine levels of COVID-19 patients after 7 days of treatment with Favipiravir or Kaletra. Int Immunopharmacol. 2021 Apr; 93:107407.
Score: 0.003
-
Myocarditis detected after COVID-19 recovery. Eur Heart J Cardiovasc Imaging. 2021 Jan 01; 22(1):131-132.
Score: 0.003
-
Clinical and demographic characteristics of patients with COVID-19 infection: Statistics from a single hospital in Iran. Hum Antibodies. 2021; 29(1):49-54.
Score: 0.003
-
Comparative evaluation of SARS-CoV-2 IgG assays against nucleocapsid and spike antigens. Hum Antibodies. 2021; 29(2):109-113.
Score: 0.003
-
SARS-CoV-2 antibody seroprevalence in the general population and high-risk occupational groups across 18 cities in Iran: a population-based cross-sectional study. Lancet Infect Dis. 2021 04; 21(4):473-481.
Score: 0.003
-
Silent hypoxia: higher NO in red blood cells of COVID-19 patients. BMC Pulm Med. 2020 Oct 16; 20(1):269.
Score: 0.003
-
Prevalence and reversibility of smell dysfunction measured psychophysically in a cohort of COVID-19 patients. Int Forum Allergy Rhinol. 2020 10; 10(10):1127-1135.
Score: 0.003
-
Clinical efficacy of convalescent plasma for treatment of COVID-19 infections: Results of a multicenter clinical study. Transfus Apher Sci. 2020 Oct; 59(5):102875.
Score: 0.003
-
Successful Treatment of Covid-19 Associated Cytokine Release Syndrome with Colchicine. A Case Report and Review of Literature. Immunol Invest. 2021 Nov; 50(8):884-890.
Score: 0.003
-
Smell dysfunction: a biomarker for COVID-19. Int Forum Allergy Rhinol. 2020 08; 10(8):944-950.
Score: 0.003
-
Blastocystis subtype 1 (allele 4); Predominant subtype among tuberculosis patients in Iran. Comp Immunol Microbiol Infect Dis. 2019 Aug; 65:201-206.
Score: 0.003
-
Common Infections and Target Organs Associated with Chronic Granulomatous Disease in Iran. Int Arch Allergy Immunol. 2019; 179(1):62-73.
Score: 0.003
-
Serum Exosomal miRNAs Are Associated with Active Pulmonary Tuberculosis. Dis Markers. 2019; 2019:1907426.
Score: 0.003
-
Revision and Implementation of "Clinical Guideline for Tuberculosis and HIV in Prisons", Great Tehran Prison, Iran. Infect Disord Drug Targets. 2018; 18(1):72-80.
Score: 0.003
-
Evidence for M2 macrophages in granulomas from pulmonary sarcoidosis: A new aspect of macrophage heterogeneity. Hum Immunol. 2018 Jan; 79(1):63-69.
Score: 0.003
-
Distribution scheme of antituberculosis drug resistance among HIV patients in a referral centre over 10 years. J Glob Antimicrob Resist. 2017 12; 11:116-119.
Score: 0.002
-
The effects of smoking on treatment outcome in patients newly diagnosed with pulmonary tuberculosis. Int J Tuberc Lung Dis. 2017 03 01; 21(3):351-356.
Score: 0.002